Myer shares rally 16% after its best result since 2014
Nick Sundich, March 9, 2023
Myer shares (ASX:MYR) rose 16% this morning and are up more than 160% in the last 12 months.
The company has shrunk significantly over the years but appears to have right-sized itself, if its 1HY23 results are anything to go by.
No time to do stock research, but you still want to invest?
Stocks Down Under Concierge gives you timely BUY and SELL alerts on ASX-listed stocks!
With price targets, buy ranges, stop loss levels and Sell alerts too.
GET A 3-MONTH FREE TRIAL TO CONCIERGE TODAY
Myer grows its profit by 101%
For the 6 months ending on January 28 2023, Myer recorded $1.9bn in overall revenue (up 24.2%) and an NPAT of $65m, the highest since 1HY23 and up 101%.
The company paid a dividend of 4c per share as well as a 4c per share special dividend.
It closed the period with a $267m net cash position (up $50m) and a favourable inventory position.
Myer told shareholders shoppers had shrugged off the cost of living crisis (so far) and return to stores over the Christmas shopping period, including CBD stores.
Although online sales declined by 9.8%, the $382.3m figure represents 31.5% 3-year CAGR growth and isn’t as sharp of a decline as other retailers.
Myer shares are performing well
As we mentioned above, Myer shares gained 16% today and are up over 160% in 12 months.
Myer (ASX:MYR) share price chart, log scale (Source: TradingView)
One holder of Myer shares who would be pleased is Solomon Lew. His investment vehicle Premier Investment now holds 25.79% of Myer shares, a figure that he recently topped up.
Stocks Down Under Concierge gives you timely BUY and SELL alerts on ASX-listed stocks!
With price targets, buy ranges, stop loss levels and Sell alerts too.
GET A 3-MONTH FREE TRIAL TO CONCIERGE TODAY
No credit card needed and the trial expires automatically.
Blog Categories
Get Our Top 5 ASX Stocks for FY25
Recent Posts
Trump vs. Jerome Powell: What Happens to the Market If Powell Is Fired?
The relationship between President Donald Trump and Federal Reserve Chair Jerome Powell has often been tumultuous, particularly around decisions regarding…
Telix Pharmaceuticals (ASX:TLX): It’s made ~A$1.7bn in revenue from Illucix, but here’s why the best is yet to come!
What would you have thought if you were told 5 years ago you would see Telix Pharmaceuticals as a successful…
Anti Woke ETFs: Do they practice what they preach and have they outperformed since Trump’s return to power?
Have you ever heard of so-called ‘Anti Woke ETFs’? If you’re sick of companies that are big on ESG, this…